<?xml version="1.0" encoding="UTF-8" standalone="no"?><ContractAwardNotice xmlns="urn:oasis:names:specification:ubl:schema:xsd:ContractAwardNotice-2" xmlns:cac="urn:oasis:names:specification:ubl:schema:xsd:CommonAggregateComponents-2" xmlns:cbc="urn:oasis:names:specification:ubl:schema:xsd:CommonBasicComponents-2" xmlns:efac="http://data.europa.eu/p27/eforms-ubl-extension-aggregate-components/1" xmlns:efbc="http://data.europa.eu/p27/eforms-ubl-extension-basic-components/1" xmlns:efext="http://data.europa.eu/p27/eforms-ubl-extensions/1" xmlns:ext="urn:oasis:names:specification:ubl:schema:xsd:CommonExtensionComponents-2">
   <ext:UBLExtensions>
      <ext:UBLExtension>
         <ext:ExtensionContent>
            <efext:EformsExtension>
               <efac:NoticeResult>
                  <cbc:TotalAmount currencyID="EUR">0.01</cbc:TotalAmount>
                  <efac:SettledContract>
                     <cbc:ID>CON-0001</cbc:ID>
                     <cbc:AwardDate>2024-03-15+01:00</cbc:AwardDate>
                     <efac:ContractReference>
                        <cbc:ID>N1.03.05.04/0012#0007</cbc:ID>
                     </efac:ContractReference>
                  </efac:SettledContract>
               </efac:NoticeResult>
               <efac:NoticeSubType>
                  <cbc:SubTypeCode listName="notice-subtype">25</cbc:SubTypeCode>
               </efac:NoticeSubType>
               <efac:Organizations>
                  <efac:Organization>
                     <efac:Company>
                        <cac:PartyIdentification>
                           <cbc:ID>ORG-0001</cbc:ID>
                        </cac:PartyIdentification>
                        <cac:PartyName>
                           <cbc:Name languageID="DEU">Paul-Ehrlich-Institut</cbc:Name>
                        </cac:PartyName>
                        <cac:PostalAddress>
                           <cbc:CityName>Langen</cbc:CityName>
                           <cbc:PostalZone>63225</cbc:PostalZone>
                           <cbc:CountrySubentityCode listName="nuts">DE71C</cbc:CountrySubentityCode>
                           <cac:Country>
                              <cbc:IdentificationCode listName="country">DEU</cbc:IdentificationCode>
                           </cac:Country>
                        </cac:PostalAddress>
                        <cac:Contact>
                           <cbc:Telephone>00496103770</cbc:Telephone>
                           <cbc:ElectronicMail>beschaffung@pei.de</cbc:ElectronicMail>
                        </cac:Contact>
                     </efac:Company>
                  </efac:Organization>
               </efac:Organizations>
            <efac:Publication><efbc:NoticePublicationID schemeName="ojs-notice-id">00166293-2024</efbc:NoticePublicationID><efbc:GazetteID schemeName="ojs-id">57/2024</efbc:GazetteID><efbc:PublicationDate>2024-03-20Z</efbc:PublicationDate></efac:Publication></efext:EformsExtension>
         </ext:ExtensionContent>
      </ext:UBLExtension>
   </ext:UBLExtensions>
   <cbc:UBLVersionID>2.3</cbc:UBLVersionID>
   <cbc:CustomizationID>eforms-sdk-1.10</cbc:CustomizationID>
   <cbc:ID schemeName="notice-id">50d6463e-8913-4ddf-9a0c-8afa34da3845</cbc:ID>
   <cbc:ContractFolderID>4caaec8b-6d6d-4fc2-9dc6-5734582bf89c</cbc:ContractFolderID>
   <cbc:IssueDate>2024-03-19Z</cbc:IssueDate>
   <cbc:IssueTime>14:15:03Z</cbc:IssueTime>
   <cbc:VersionID>01</cbc:VersionID>
   <cbc:RegulatoryDomain>32014L0024</cbc:RegulatoryDomain>
   <cbc:NoticeTypeCode listName="dir-awa-pre">veat</cbc:NoticeTypeCode>
   <cbc:NoticeLanguageCode listName="language">DEU</cbc:NoticeLanguageCode>
   <cac:ContractingParty>
      <cac:ContractingPartyType>
         <cbc:PartyTypeCode listName="buyer-legal-type">body-pl-cga</cbc:PartyTypeCode>
      </cac:ContractingPartyType>
      <cac:ContractingActivity>
         <cbc:ActivityTypeCode listName="authority-activity">health</cbc:ActivityTypeCode>
      </cac:ContractingActivity>
      <cac:Party>
         <cac:PartyIdentification>
            <cbc:ID>ORG-0001</cbc:ID>
         </cac:PartyIdentification>
      </cac:Party>
   </cac:ContractingParty>
   <cac:TenderingProcess>
      <cbc:ProcedureCode listName="procurement-procedure-type">neg-wo-call</cbc:ProcedureCode>
   </cac:TenderingProcess>
   <cac:ProcurementProject>
      <cbc:Name languageID="DEU">Erweiterungen am Deutschen Hämophiliregister (DHR)</cbc:Name>
      <cbc:Description languageID="DEU">Erweiterungen am Deutschen Hämophiliregister (DHR) für die Anwendungsbegleitende Datenerhebung im Rahmen von Studien pharmazeutischer Unternehmer zur Nutzenbewertung von Gentherapeutika</cbc:Description>
      <cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
      <cac:MainCommodityClassification>
         <cbc:ItemClassificationCode listName="cpv">72260000</cbc:ItemClassificationCode>
      </cac:MainCommodityClassification>
      <cac:RealizedLocation>
         <cac:Address>
            <cbc:CountrySubentityCode listName="nuts">DE71C</cbc:CountrySubentityCode>
            <cac:Country>
               <cbc:IdentificationCode listName="country">DEU</cbc:IdentificationCode>
            </cac:Country>
         </cac:Address>
      </cac:RealizedLocation>
   </cac:ProcurementProject>
   <cac:ProcurementProjectLot>
      <cbc:ID schemeName="Lot">LOT-0001</cbc:ID>
      <cac:TenderingTerms>
         <cac:AppealTerms>
            <cac:AppealReceiverParty>
               <cac:PartyIdentification>
                  <cbc:ID>ORG-0001</cbc:ID>
               </cac:PartyIdentification>
            </cac:AppealReceiverParty>
         </cac:AppealTerms>
      </cac:TenderingTerms>
      <cac:TenderingProcess>
         <cbc:GovernmentAgreementConstraintIndicator>true</cbc:GovernmentAgreementConstraintIndicator>
      </cac:TenderingProcess>
      <cac:ProcurementProject>
         <cbc:ID>N1.03.05.04/0012#0007</cbc:ID>
         <cbc:Name languageID="DEU">Erweiterungen am Deutschen Hämophiliregister (DHR)</cbc:Name>
         <cbc:Description languageID="DEU">Erweiterungen am Deutschen Hämophiliregister (DHR) für die Anwendungsbegleitende Datenerhebung im Rahmen von Studien pharmazeutischer Unternehmer zur Nutzenbewertung von Gentherapeutika.
Es handelt sich um eine technische Alleinstellung. Der derzeitige Betreiber des DHR ist das einzige Unternehmen, das aufgrund des Aufbaus der vorhandenen Datenbank sowie der Entwicklung des verwendeten Pseudonymisierungsverfahrens die erforderlichen Anpassungen und Erweiterungen vornehmen kann.</cbc:Description>
         <cbc:ProcurementTypeCode listName="contract-nature">services</cbc:ProcurementTypeCode>
         <cac:MainCommodityClassification>
            <cbc:ItemClassificationCode listName="cpv">72260000</cbc:ItemClassificationCode>
         </cac:MainCommodityClassification>
      </cac:ProcurementProject>
   </cac:ProcurementProjectLot>
   <cac:TenderResult>
      <cbc:AwardDate>2000-01-01Z</cbc:AwardDate>
   </cac:TenderResult>
</ContractAwardNotice>